CJC-1295 No DAC (5 mg) & Ipamorelin (5 mg) – Research Peptide Blend
This peptide formulation combines CJC-1295 No DAC (5 mg) and Ipamorelin (5 mg) in a single vial for laboratory research purposes only. Developed for researchers investigating peptide behavior, growth hormone signaling, and related biochemical pathways, this blend offers a practical option for experimental study. Each vial is synthesized under controlled conditions and quality-tested to ensure high purity and consistency. This product is intended strictly for scientific research and analytical use and is not approved for human or veterinary applications.
Research Overview
Scientific interest in CJC-1295 No DAC and Ipamorelin centers on their roles in growth hormone (GH) modulation. While limited studies examine this exact combination, existing research on each peptide individually provides a strong foundation for investigating their combined effects.
CJC-1295 No DAC has been shown in preclinical research to stimulate sustained growth hormone release, with elevated GH and insulin-like growth factor 1 (IGF-1) levels observed for several days following administration in animal models. Ipamorelin, by contrast, is known for inducing short, pulsatile GH release while maintaining selectivity for GH pathways and minimizing activity on other hormonal systems. Additional research suggests Ipamorelin may influence bone formation processes through increased mineralization and new tissue deposition.
When studied together, a GHRH analog such as CJC-1295 No DAC and a GHRP like Ipamorelin may demonstrate synergistic GH stimulation. This combination allows researchers to examine both prolonged and pulsatile GH activity within a single experimental model, offering insight into GH-related mechanisms associated with metabolism, tissue development, and aging.
Research Highlights
- Sustained GH and IGF-1 elevation observed with CJC-1295 No DAC in preclinical studies
- Selective, pulsatile GH release associated with Ipamorelin
- Combined use may enhance overall GH activity over time in research settings
Disclaimer
All information provided is derived from in vitro or animal-based research and is presented for educational and scientific discussion only. This peptide blend is intended exclusively for research use and is not intended for human consumption, medical use, or therapeutic application.
Note: This product is provided as a Lyophilized, research-grade powder and does not come in liquid form.
Disclaimer
Research Use Only Disclaimer:
Products from Flawless BioLabs are strictly for laboratory and research use by qualified professionals. They are not pharmaceuticals, dietary supplements, agricultural products, or household items, and must not be mislabeled as such. These chemicals are not intended for human or veterinary use and are exempt from Title 21, Parts 100–740 of the CFR. The information provided is educational, has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any health condition.
Intellectual Property & Patent Use Disclaimer: Flawless BioLabs provides this product solely for uses that fall under exemptions to patent infringement as permitted by applicable law, including but not limited to 35 U.S.C. § 271(e)(1) in the United States. It is the sole responsibility of the purchaser or user to ensure that their use of this product complies with all applicable intellectual property laws and legal exemptions. By purchasing this product, the buyer agrees to use it only within the scope of those exemptions and to indemnify and hold harmless Flawless BioLabs from any claims arising from its use, including any alleged intellectual property infringement.
